TITLE

Review: Intravenous metoclopramide is better than placebo for reducing pain in acute migraine in the emergency department: COMMENTARY

AUTHOR(S)
Loder, Elizabeth W.
PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p77
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information related to the drug Metoclopramide that avoids many perceived or actual liabilities of other current treatment choices for acute migraine. It also provides relief of pain and other such migraine-associated symptoms such as nausea and vomiting. Although the results show a reduction in pain that favors metoclopramide over placebo, the duration of effect and rate of headache relapse are not known. However, metoclopramide alone does provide definitive treatment for some patients. 3 of 4 patients on average will require alternative or adjunctive treatment.
ACCESSION #
17116549

 

Related Articles

  • MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments. TEPPER, STEWART J.; KOIU, SHASHIDHAR H.; GOADSBY, PETER J.; WINNER, PAUL K.; WANG, MIN H.; SILBERSTEIN, STEPHEN D.; CUTRER, F. MICHAEL // Mayo Clinic Proceedings;Oct2011, Vol. 86 Issue 10, p948 

    OBJECTIVE: To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamlne, for acute treatment of migraine when admin- istered at various time points from within 1 hour to more than 8 hours after migraine onset. PATIENTS AND METHODS: This post hoc subanalysis was con- ducted using data...

  • Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study. Bussone, G.; Usai, S.; D'Amico, D. // Neurological Sciences;May2006 Supplement 2, Vol. 27, ps159 

    Topiramate is approved for the preventive treatment of migraine in several countries based on the results of three large randomised, double-blind studies that showed that this compound was significantly more effective than placebo in migraine prophylaxis. We review the results of two studies:...

  • Almotriptan elevates QOL for migraine sufferers.  // PharmacoEconomics & Outcomes News;4/19/2008, Issue 551, p10 

    The article discusses research being done on the use of almotriptan for the treatment of migraine. It references a study by Freitag F. Smith, T. Mathew et al, published in the March 2008 issue of "Headache." U.S. researchers assessed data for migraine patients who were randomised to treat three...

  • Eletriptan: A Review of its Use in the Acute Treatment of Migraine. McCormack, Paul L.; Keating, Gillian M. // Drugs;2006, Vol. 66 Issue 8, p1129 

    Eletriptan (Relpax) is an orally administered, lipophilic, highly selective serotonin 5-HT1B/1D receptor agonist (‘triptan’) that is effective in the acute treatment of moderate to severe migraine attacks in adults. It has a rapid onset of action and demonstrates...

  • Topiramate for Migraine Prevention: A Randomized Controlled Trial. Brandes, Jan Lewis; Saper, Joel R.; Diamond, Merle; Couch, James R.; Lewis, Donald W.; Schmitt, Jennifer; Neto, Walter; Schwabe, Stefan; Jacobs, David // JAMA: Journal of the American Medical Association;2/25/2004, Vol. 291 Issue 8, p965 

    Context: Small open-label and controlled trials suggest that the antiepileptic drug topiramate is effective for migraine prevention. Objective: To assess the efficacy and safety of topiramate for migraine prevention in a large controlled trial. Design, Setting, and Patients: A 26-week,...

  • Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence: A Randomised, Placebo-Controlled Trial. Ryan, R.E.J.; Diamond, S.; Giammarco, R.A.; Aurora, S.K.; Reed, R.C.; Fletcher, P.E. // CNS Drugs;2000, Vol. 13 Issue 3, p215 

    Objective and Study Design: This double-blind, placebo-controlled trial assessed the efficacy of zolmitriptan versus placebo at early time-points post-dose as an acute treatment for migraine and treatment of headache recurrence. Patients and Methods: Patients (18 to 65 years) with a...

  • Headache therapy with neuronal stabilising drugs. Colombo, Bruno; Libera, Dacia; Annovazzi, Pietro Oreste; Comi, Giancarlo // Neurological Sciences;May2008 Supplement 1, Vol. 29, p131 

    Migraine is a frequent episodic condition that often requires prophylaxis treatment to reduce the severity, frequency and duration of attacks and to ameliorate disability. Migraine can be interpreted as a disorder of pain modulation, which involves the trigeminovascular system and central...

  • Topiramate improves daily activities for patients with migraine.  // PharmacoEconomics & Outcomes News;8/12/2006, Issue 509, p8 

    The article discusses the study "The Impact of Migraine on Daily Activities: Effect of Topiramate Compared With Placebo Study on the Benefits of Using Topiramate to Patients With Migraine," by S. D. Silberstein, E. Loder et al published in the June 2006 issue of "Current Medical Research and...

  • Clinical Study on Effect of Xiaoyao Nose Drops in Stopping Episode of Migraine. Hu Huai-qiang; Zhou Yong-hong; Wang Xin-lu // Chinese Journal of Integrative Medicine;Jun2006, Vol. 12 Issue 2, p112 

    Objective: To observe the effect of Xiaoyao Nose Drops (XYND) in stopping episode of migraine Methods= Adopted was the randomized double-blinded placebo-controled method, with the 126 patients equally assigned to two groups, the treated group treated with XYND and the control group with placebo,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics